CTLA4 and rheumatoid arthritis: Agg-CLNP demonstrated robust DC immunomodulation in vitro in monocyte-derived DC sourced from healthy humanand RA patient blood, reducing the expression of costimulatory moleculesand HLA-2 and upregulating CTLA-4.